Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT02730247 · COMPLETED
Trial details
- NCT number
- NCT02730247
- Sponsor
- Liza Villaruz, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-05
- Primary completion
- 2019-09-08
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.